The Patent Finder

Io Therapeutics, Inc.

Also on record
Records under this name other than the patents Io Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 52 patents it holds.

Back to Io Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,034,845Autoimmune disorder treatment using RXR agonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,201,512Autoimmune disorder treatment using RXR agonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,285,960Autoimmune Disorder Treatment using RXR Agonists
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,166,927Autoimmune disorder treatment using RXR agonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,246,845Autoimmune disorder treatment using RXR agonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,793,781Autoimmune disorder treatment using RXR agonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,547,684Autoimmune disorder treatment using RXR agonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,383,521Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,653,650Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,940,127Use of CYP26-Resistant Rar Alpha Selective Agonists in the Treatment of Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
10 of 30 patents shown.
Pro members see all 30.
Pro members: see all 30 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited